Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis

Cytokine

Volumn 61, Issue 3, 2013, Pages 862-875

  Blalock, Emily L ^a   Chien, Hsin ^a   Dix, Richard D ^a,b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Human cytomegalovirus; Interleukin 10; Interleukin 17; Suppressor of cytokine signaling 3

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DISEASE COURSE; DOWN REGULATION; FEMALE; HELPER CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETINA CONE; RETROVIRUS; RNA EXTRACTION; SPLEEN CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS RETINITIS; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; EYE; FEMALE; IMMUNOSUPPRESSION; INTERLEUKIN-17; MACROPHAGES; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; MUROMEGALOVIRUS; NEUTROPHILS; PHOTORECEPTOR CELLS, VERTEBRATE; RETROVIRIDAE; RNA, MESSENGER; SPLEEN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

ANIMALIA; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1; MUS;

EID: 84875376457     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.01.009     Document Type: Article

References (67)

1. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996, 17:138-146.
2. Cherwinski H.M., Schumacher J.H., Brown K.D., Mosmann T.R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987, 166:1229-1244.
3. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
4. Wan Y.Y. Multi-tasking of helper T cells. Immunology 2010, 130:166-171.
5. Bettelli E., Korn T., Kuchroo V.K. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007, 19:652-657.
6. Furuzawa-Carballeda J., Vargas-Rojas M.I., Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007, 6:169-175.
7. Schmidt-Weber C.B., Akdis M., Akdis C.A. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007, 120:247-254.
8. Annunziato F., Cosmi L., Romagnani S. Human and murine Th17. Curr Opin HIV AIDS 2010, 5:114-119.
9. Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009, 9:556-567.
10. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852.
11. Stockinger B, Veldhoen M, Martin B. Th17 T cells: linking innate and adaptive immunity. Semin Immunol 2007.
12. Lovett-Racke A.E., Yang Y., Racke M.K. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?. Biochim Biophys Acta 2011, 1812:246-251.
13. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517.
14. Luger D., Caspi R.R. New perspectives on effector mechanisms in uveitis. Semin Immunopathol 2008, 30:135-143.
15. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
16. Caspi R. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol Res 2008, 42:41-50.
17. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007, 13:711-718.
18. Peng Y., Han G., Shao H., Wang Y., Kaplan H.J., Sun D. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2007, 48:4153-4161.
19. Caspi R.R. A look at autoimmunity and inflammation in the eye. J Clin Invest 2010, 120:3073-3083.
20. Jabs D.A. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc 1995, 93:623-683.
21. Jabs D.A. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome-bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol 2011, 151:198-216.
22. Knipe DM, Howley PM. Fields virology, vol. 2, 5th ed.; 2007. p. 2701-72.
23. Crough T., Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009, 22:76-98.
24. Reddehase M.J. Cytomegaloviruses: molecular biology and immunology 2006, Caister Academic Press, Norfolk.
25. Dix R.D., Cousins S.W. AIDS-related cytomegalovirus retinitis: lessons from the laboratory. Curr Eye Res 2004, 29:91-101.
26. Gallant J.E., Moore R.D., Richman D.D., Keruly J., Chaisson R.E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 1992, 166:1223-1227.
27. Heiden D., Ford N., Wilson D., Rodriguez W.R., Margolis T., Janssens B., et al. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med 2007, 4:e334.
28. Stewart M.W. Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol 2010, 4:285-299.
29. Brenchley J.M., Paiardini M., Knox K.S., Asher A.I., Cervasi B., Asher T.E., et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112:2826-2835.
30. Yue F.Y., Merchant A., Kovacs C.M., Loutfy M., Persad D., Ostrowski M.A. Virus-specific interleukin-17-producing CD4+ T cells are detectable in early human immunodeficiency virus type 1 infection. J Virol 2008, 82:6767-6771.
31. Maek A.N.W., Buranapraditkun S., Klaewsongkram J., Ruxrungtham K. Increased interleukin-17 production both in helper T cell subset Th17 and CD4-negative T cells in human immunodeficiency virus infection. Viral Immunol 2007, 20:66-75.
32. Dix R.D., Cray C., Cousins S.W. Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis. Curr Eye Res 1994, 13:587-595.
33. Morse H.C., Giese N., Morawetz R., Tang Y., Gazzinelli R., Kim W.K., et al. Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springer Semin Immunopathol 1995, 17:231-245.
34. Atherton S.S., Newell C.K., Kanter M.Y., Cousins S.W. Retinitis in euthymic mice following inoculation of murine cytomegalovirus (MCMV) via the supraciliary route. Curr Eye Res 1991, 10:667-677.
35. Gu Y., Yang J., Ouyang X., Liu W., Li H., Bromberg J., et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 2008, 38:1807-1813.
36. Dix R.D., Cousins S.W. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma. Curr Eye Res 2004, 29:173-180.
37. Chien H, Dix RD. Evidence For multiple cell death pathways during development of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression: apoptosis, necroptosis, and pyroptosis. J Virol 2012.
38. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA 2006, 103:8137-8142.
39. Yoshimura A., Naka T., Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007, 7:454-465.
40. Tanaka K., Ichiyama K., Hashimoto M., Yoshida H., Takimoto T., Takaesu G., et al. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J Immunol 2008, 180:3746-3756.
41. Akhtar L.N., Benveniste E.N. Viral exploitation of host SOCS protein functions. J Virol 2011, 85:1912-1921.
42. Akhtar L.N., Qin H., Muldowney M.T., Yanagisawa L.L., Kutsch O., Clements J.E., et al. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. J Immunol 2010, 185:2393-2404.
43. Huber S., Gagliani N., Esplugues E., O'Connor W., Huber F.J., Chaudhry A., et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 2011, 34:554-565.
44. Chaudhry A., Samstein R.M., Treuting P., Liang Y., Pils M.C., Heinrich J.M., et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011, 34:566-578.
45. Guillemin G.J., Brew B.J. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukocyte Biol 2004, 75:388-397.
46. Chen L., Yang P., Kijlstra A. Distribution, markers, and functions of retinal microglia. Ocul Immunol Inflamm 2002, 10:27-39.
47. Crane I.J., Liversidge J. Mechanisms of leukocyte migration across the blood-retina barrier. Semin Immunopathol 2008, 30:165-177.
48. Yue F.Y., Merchant A., Kovacs C.M., Loutfy M., Persad D., Ostrowski M.A. Virus-specific interleukin-17-producing CD4+ T cells are detectable in early human immunodeficiency virus type 1 infection. J Virol 2008, 82:6767-6771.
49. Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011, 34:149-162.
50. Stockinger B., Veldhoen M., Martin B. Th17 T cells: linking innate and adaptive immunity. Semin Immunol 2007, 19:353-361.
51. Miller-Kittrell M., Sparer T.E. Feeling manipulated: cytomegalovirus immune manipulation. Virol J 2009, 6:4.
52. Kalejta R.F. Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev 2008, 72:249-265.
53. Arnon T.I., Achdout H., Levi O., Markel G., Saleh N., Katz G., et al. Inhibition of the NKp30 activating receptor by pp 65 of human cytomegalovirus. Nat Immunol 2005, 6:515-523.
54. Cranmer L.D., Clark C.L., Morello C.S., Farrell H.E., Rawlinson W.D., Spector D.H. Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp 71) and UL83 (pp65) matrix phosphoproteins. J Virol 1996, 70:7929-7939.
55. Kattenhorn L.M., Mills R., Wagner M., Lomsadze A., Makeev V., Borodovsky M., et al. Identification of proteins associated with murine cytomegalovirus virions. J Virol 2004, 78:11187-11197.
56. Loewendorf A., Benedict C.A. Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J Intern Med 2010, 267:483-501.
57. Loewendorf A.I., Steinbrueck L., Peter C., Busche A., Benedict C.A., Kay-Jackson P.C. The mouse cytomegalovirus glycoprotein m155 inhibits CD40 expression and restricts CD4 T cell responses. J Virol 2011, 85:5208-5212.
58. Mocarski E.S. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 2002, 10:332-339.
59. Wagner M., Gutermann A., Podlech J., Reddehase M.J., Koszinowski U.H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 2002, 196:805-816.
60. Elgueta R., Benson M.J., de Vries V.C., Wasiuk A., Guo Y., Noelle R.J. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 2009, 229:152-172.
61. Ma D.Y., Clark E.A. The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol 2009, 21:265-272.
62. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., Fujii N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication. Virology 2005, 338:173-181.
63. Frey K.G., Ahmed C.M., Dabelic R., Jager L.D., Noon-Song E.N., Haider S.M., et al. HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion. J Immunol 2009, 183:1253-1262.
64. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J Immunol 2008, 180:5771-5777.
65. Humphreys I.R., de Trez C., Kinkade A., Benedict C.A., Croft M., Ware C.F. Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J Exp Med 2007, 204:1217-1225.
66. Redpath S., Angulo A., Gascoigne N.R., Ghazal P. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol 1999, 162:6701-6707.
67. Sabat R., Grutz G., Warszawska K., Kirsch S., Witte E., Wolk K., et al. Biology of interleukin-10. Cytokine Growth Factor Rev 2010, 21:331-344.